Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval

URN to cite this document:: urn:nbn:de:bvb:355-epub-545805
DOI to cite this document:: 10.5283/epub.54580

Michel, Holger ; Potapow, Antonia ; Dechant, Markus-Johann ; Brandstetter, Susanne

; Wellmann, Sven

; Köninger, Angela ; Melter, Michael

; Apfelbacher, Christian J.

; Kabesch, Michael

; Gerling, Stephan

License: Creative Commons Attribution 4.0
PDF - Published Version
(772kB)

Date of publication of this fulltext: 09 Aug 2023 08:16

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Introduction: Acquired QT interval prolongations due to drug side effects can result in detrimental arrhythmia. Maternal use of placenta-permeable drugs may lead to fetal exposure, thus leading to an increased risk of neonatal QT prolongation and arrhythmia. Objectives: This study aimed to evaluate the influence of maternal QT-prolonging medication on the neonatal QT interval. Methods: In ...